Join Georgia Bio, NCLifeSci, VABio, and Life Science Nation to learn why you should attend RESI South on March 25 in Atlanta.
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.
This webinar will cover the following:
- Life Science Nation (LSN) and RESI conference introduction (format, attendees, etc)
- Why Attend RESI South?
- LSN’s relationships with investors (how LSN sources and maintains relationships with them)
- Opportunity for Q&A
